Correction for Oka et al., " In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile "

Affiliations

• ¹ Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ² Department of Drug Metabolism and Pharmacokinetics, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ³ Department of Investigative Toxicology, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ⁴ Department of Drug Safety Research, Nonclinical Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ⁵ Otsuka Shanghai Research Institute, Shanghai, China.
• ⁶ Infectious Diseases Unit, Department of Medical Innovations, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ⁷ Medicinal Chemistry Research Laboratories, New Drug Research Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Japan.
• ⁸ Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan.